The 1.5 mg dose is intended for treatment initiation and is not effective for glycemic control
No safety depends on proper prescribing and monitoring
As a dual GIP/GLP-1 receptor agonist, Tirzepatide may help increase insulin sensitivity, reduce body fat, stabilize glucose levels
These two medications have made headlines for their effectiveness in helping people lose weight, but how do you decide which is right for you
Retrieved from Novo Nordisk ( c)
After struggling with postpartum weight gain and yo-yo diets for years, Manon reflects on her Enhance.MD experience, calling it, Very easy and very affordable. Updated April 2025: We updated this article since publishing in August 2024 to reflect the most recent information about Enhance.MDs GLP-1 program, including pricing, availability and other important details